Clinical Trial Agreement Form

PandaTip: This section of the Clinical Trials Agreement Template provides you with an area in which you can document all proprietary rights between the parties as well as all other proprietary rights that participate in the Clinical Trials Agreement. The revision of the Clinical Trials Agreement is limited to the following two aspects, based on the CCMO Directive on the Evaluation of Clinical Trial Agreements: the CCMO considers that the clauses relating to the early termination of the study and the publication in these models are in line with the CCMO Directive on the Evaluation of Clinical Trial Agreements. The institution shall reimburse all parties for all expenses and expenses resulting from the main hearing during or after the trial period. All other products and documents are the property of the institution and will remain so after completion and for the duration of the study. The invalidity or unenforceability of any provision or provision shall not affect any other conditions set forth in this Clinical Trials Agreement. In the event that any provision is held to be unenforceable or invalid, all other provisions will remain in full force and application. The sponsor has agreed to financially support the clinical trial as follows: if the sponsor submitted an unsigned version at the time of the first application, the sponsor must submit to the trial committee a signed agreement for the clinical trial before the start of the trial. In the attached cover letter, you must indicate whether the provisions evaluated by the evaluation committee have been modified in the signed research contract. . . .